Cross Research
Cross Research is recorded as a service provider in 3 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 3 of 3 trials · Latest update first
A Phase I/II safety and efficacy study of Vibrio alginolyticus collagenase in patients with Peyronie’s Disease
Sponsor Fidia Farmaceutici S.p.A.
- Start (EU)
- Latest update
- Estimated end
- Not reported
A Phase I/II study of Vibrio alginolyticus collagenase in patients with Dupuytren contracture. A Phase I single ascending dose with a Phase II expansion, safety, tolerability, efficacy, pharmacokinetics and immunogenicity study
Sponsor Fidia Farmaceutici S.p.A.
- Start (EU)
- Latest update
- Estimated end
- Not reported
A Phase 1/2a Double-Blind, Placebo-controlled, Single- and Multiple-Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Clinical Efficacy of Intravenous Administration of ATX-01 In Male and Female Participants aged 18 to 64 with Classic Myotonic Dystrophy Type 1 (DM1)
Sponsor Arthex Biotech S.L.
- Start (EU)
- Latest update
- Estimated end
Questions about this trial experience
What services are recorded for Cross Research?
The 2026-10-09 snapshot links Cross Research to 3 distinct CTIS trials. Recorded services include Clinical monitoring, Data management, Medical writing, Project management, among 7 recorded service labels. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Cross Research?
The most frequently recorded therapeutic areas are Musculoskeletal, Urology. Recorded phases include Phase 1, Phase 2. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Cross Research conducted?
The linked trials record locations in 7 countries, including Italy, Austria, Germany, Spain, France. These are trial locations, not confirmed office locations or countries where Cross Research delivered services.
What can this page tell me about Cross Research's trial experience?
Browse 3 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Cross Research. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Cross Research S.A.